Human LMOD1 ELISA Kit (V2LY-0626-LY829)

Fournier, N., & Fabre, A. (2022). Smooth muscle motility disorder phenotypes: A systematic review of cases associated with seven pathogenic genes (ACTG2, MYH11, FLNA, MYLK, RAD21, MYL9 and LMOD1). Intractable & Rare Diseases Research, 11(3), 113-119.

Tan, Y., Chen, Q., Pan, S., An, W., Xu, H., Xing, Y., & Zhang, J. (2022). LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT/mTOR pathway. BMC cancer, 22(1), 474.

Kosiński, K., Malinowski, D., Safranow, K., Dziedziejko, V., & Pawlik, A. (2022). PECAM1, COL4A2, PHACTR1, and LMOD1 Gene Polymorphisms in Patients with Unstable Angina. Journal of Clinical Medicine, 11(2), 373.

Liu, K., Lu, L., Chen, S., Gu, B., Cai, H., Wang, Y., & Cai, W. (2022). Loss‐of‐function variants within LMOD1 actin‐binding site 2 cause pediatric intestinal pseudo‐obstruction by impairing protein stability and actin nucleation. The FASEB Journal, 36(3), e22194.

Qiao, X., Fu, S., Duan, X., Zuo, Y., Zhu, X., Wang, H., & Wang, J. (2021). MYLK, CNN1, TAGLN and LMOD1 identified as potential prognostic biomarkers for bladder cancer using bioinformatics analysis.

Nanda, V., Wang, T., Pjanic, M., Liu, B., Quertermous, T., Miano, J., ... & Miller, C. L. (2018). Regulatory Mechanism of Lmod1 Mediated Predisposition to Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 38(Suppl_1), A619-A619.

Nanda, V., Wang, T., Pjanic, M., Liu, B., Nguyen, T., Matic, L. P., ... & Miller, C. L. (2018). Functional regulatory mechanism of smooth muscle cell-restricted LMOD1 coronary artery disease locus. PLoS genetics, 14(11), e1007755.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols